Related Experiment Videos

Met-enkephalin induced alterations of macrophage functions

Molecular Immunology
|August 1, 1984
PubMed

Insights

Met-enkephalin stimulates antibody-dependent cell-mediated cytotoxicity in rat macrophages via opiate receptors. This peptide also affects phagocytosis and chemiluminescence, indicating complex immunomodulatory roles.

Area of Science:

  • Immunology
  • Neuroendocrinology
  • Cellular Biology

Background:

  • Opioid peptides, such as Met-enkephalin, are known to modulate immune cell functions.
  • Rat peritoneal macrophages are key effector cells in cellular immunity.

Purpose of the Study:

  • To investigate the effects of Met-enkephalin on rat peritoneal macrophage functions, specifically antibody-dependent cell-mediated cytotoxicity (ADCC).
  • To explore the receptor pathways and intracellular mechanisms involved in Met-enkephalin's immunomodulatory actions.

Main Methods:

  • Assessing Met-enkephalin's effect on IgG2a-mediated ADCC using 51Cr-labeled sheep red blood cells.
  • Measuring phagocytosis of antibody-coated target cells.
  • Quantifying luminol-dependent chemiluminescence (LDCL) as an indicator of oxidative burst.
  • Utilizing naloxone to block opiate receptors and trifluoperazine (TFP) to inhibit calmodulin.
  • Analyzing cyclic guanosine monophosphate (cGMP) levels in treated macrophages.

Main Results:

  • Met-enkephalin (10^-9 - 10^-7 M) significantly stimulated IgG2a-mediated ADCC in rat peritoneal macrophages through naloxone-sensitive opiate receptors.
  • Phagocytosis of IgG2a-coated SRBC was suppressed by Met-enkephalin in the same concentration range.
  • Met-enkephalin induced a significant increase in LDCL generation.
  • The Met-enkephalin-induced stimulation of ADCC was abolished by the calmodulin inhibitor TFP (10^-6 M).
  • Met-enkephalin treatment led to augmented cGMP accumulation in peritoneal macrophages.

Conclusions:

  • Met-enkephalin modulates rat peritoneal macrophage functions, enhancing ADCC and LDCL while suppressing phagocytosis.
  • The effects are mediated via naloxone-sensitive opiate receptors and involve calmodulin and cGMP signaling pathways.
  • These findings highlight the intricate interplay between the neuroendocrine and immune systems.

Related Concept Videos